Key facts
- Petscribers’s last known valuation is $1.8M (Aug 2025).
- It has raised $400K; the latest was Angel (individual) ($400K) in Aug 2025.
- Notable investors include MAINstream (UK).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Petscribers
- ·The full record, as it builds
Funding rounds
No funding rounds for Petscribers are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Petscribers
Operator of a digital platform intended to simplify the process of purchasing veterinary medications online. The company's platform provides a comprehensive and integrated system for pet owners to find, compare, and purchase prescribed medications from approved pharmacies, enabling pet owners to access a wider range of affordable medications.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Malmesbury, United Kingdom
- Founded
- 2021
- Employees
- 5
- Website
- petscribers.co.uk/
- Ownership
- Privately Held (backing)
Petscribers doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Petscribers shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Petscribers in its N-PORT filings yet. We sweep new filings monthly.